New Stock News | It is reported that Shenzhen Woer Heat-shrinkable Material (002130.SZ) is currently conducting a pre-IPO roadshow in Hong Kong, aiming to raise up to 400 million US dollars.
Market reports indicate that Wuhan Atomaterials (002130.SZ) is currently conducting a pre-IPO roadshow, aiming to raise between $300 million and $400 million.
Market rumors indicate that Shenzhen Woer Heat-shrinkable Material (002130.SZ) is currently conducting pre-listing roadshows, planning to raise between 300 million and 400 million US dollars. According to the Hong Kong Stock Exchange, Shenzhen Woer Heat-shrinkable Material held a listing hearing on the main board of the Hong Kong Stock Exchange on January 27, with China Securities Co., Ltd and CMSC International as its joint sponsors.
Public information shows that Shenzhen Woer Heat-shrinkable Material was established in 1998 and listed on the Shenzhen Stock Exchange in 2007. It is one of the world's largest manufacturers of heat shrinkable materials and communication cable products, with main businesses including electronic communication, power transmission, and other sectors.
According to Frost & Sullivan data, the company ranks first in the global heat shrinkable materials industry, with a 20.6% market share by 2024 global revenue. By 2024 global revenue, the company ranks third among global telecom cable manufacturers (including high-speed copper cables), with a 12.7% market share.
Financially, in the fiscal years 2022, 2023, 2024, and the nine months ending September 30, 2025, the company achieved revenues of approximately 5.337 billion RMB, 5.719 billion RMB, 6.92 billion RMB, and 6.077 billion RMB respectively. During the same period, it recorded net profits of approximately 660 million RMB, 758 million RMB, 921 million RMB, and 883 million RMB.
Related Articles

New Stock Preview | From "Deep Squatting" in Performance to Global Leapfrogging: Decoding the Breakthrough Logic of Sirio Pharma (300791.SZ)

From the sharp decline in the entrance to the "doji star", is the reversal of the low-stage consolidation of INNOGEN-B (02591) imminent?

New stock preview | Hujia Technology: Dual pressure of single brand and online dependence Can high-tech profit margins continue?
New Stock Preview | From "Deep Squatting" in Performance to Global Leapfrogging: Decoding the Breakthrough Logic of Sirio Pharma (300791.SZ)

From the sharp decline in the entrance to the "doji star", is the reversal of the low-stage consolidation of INNOGEN-B (02591) imminent?

New stock preview | Hujia Technology: Dual pressure of single brand and online dependence Can high-tech profit margins continue?

RECOMMEND

Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
30/01/2026

Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
30/01/2026

2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
30/01/2026


